Table 2.
Treatment outcome from Papua TES during the 42 day of follow-up
| Classification of treatment outcome | Papua | |||
|---|---|---|---|---|
| Microscopy result (without PCR correction) | With PCR correction | |||
| n | % (95% CI)a | n | % (95% CI)a | |
| Total patient’s treatment failure and completed the 42 day-follow-up | ||||
| Treatment failure | ||||
| ETF | 0 | 0% (0.0–3.1) | 0 | 0% (0.0–3.4) |
| LCF | 0 | 0% (0.0–3.1) | 0 | 0% (0.0–3.4) |
| LPF | 10 | 8.5% (4.2–15.2) | 1 | 0.9% (0.0–5.1) |
| ACPR | 107 | 91.5% (84.8–95.8) | 107 | 99.1% (94.9–100.0) |
| Patient LFU/WTH | 25 | – | 34 | – |
| Total patients at baseline | 142 | – | 142 | – |
ETF early treatment failure, LCF late clinical failure, LPF late parasitological failure, LFU lost to follow up, WTH withdrawn
aKaplan–Meier analysis